Emergen Research Logo

Antibody-Drug Conjugates (ADCs) Market Trends – Increasing prevalence of cancer globally

VANCOUVER, BC, CANADA, August 16, 2022 /EINPresswire.com/ -- The Global Antibody-Drug Conjugates Market report assesses the historical and current data along with a thorough analysis of the market dynamics. The report also sheds light on the significant market growth driving and restraining factors that are anticipated to influence the market growth through the forecast period. The Global Antibody-Drug Conjugates Market studies the market scenario to offer growth projections for the Antibody-Drug Conjugates industry for the forecast period of 2020-2028.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/754

The global Antibody-Drug Conjugates (ADCs) market size is expected to reach USD 20.01 Billion at a steady revenue CAGR of 25.8% in 2028, according to latest analysis by Emergen Research. Increasing prevalence of cancer along with growing geriatric population is driving antibody-drug conjugates market revenue growth. Antibody drug conjugates are used to treat cancer and are safer than other types of cancer therapies.

Antibody-drug conjugates are highly targeted therapies that use biopharmaceutical drugs comprising monoclonal antibodies to target tumor cell specific antigens and extremely potent anti-cancer drugs linked through chemical linker. ADCs are considered a powerful and highly effective class of therapeutic agents used in oncology and hematology. ADC technology is also used outside of cancer-related indications.

Competitive Landscape:

The Antibody-Drug Conjugates report focuses on potential growth opportunities and limitations the prominent players of the industry might face during the entirety of the forecast timeline. The report pays special heed to the emerging business components, niche sectors, and product launches and brand promotions occurring in the Antibody-Drug Conjugates market to help the readers make fruitful investment strategies.

The major companies studied in the report are:
Oxford BioTherapeutics, Bayer AG, Immunomedics Inc., Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Pfizer Inc., ImmunoGen Inc., AbbVie Inc., Sanofi S.A. and Takeda Pharmaceutical Company Limited

Some Key Highlights from the Report
In July 2021, ProfoundBio announced completion of USD 55 million Series A funding on advance novel antibody-drug conjugate portfolio. The financing is being led by Lilly Asia Venture and co-led by LYFE Capital, with participation from Oriza and Sequoia Capital China. ProfoundBio will use the funds to accelerate development of ADCs and IO therapeutics.
Non-cleavable linkage segment accounted for larger revenue share in 2020 owing to greater advantages over cleavable linkers due to increased plasma stability. These linkers can potentially offer a greater therapeutic window due to the fact that the payload derivative from non-cleavable ADCs can kill target cells. It also provides great tolerability and stability.
Lung cancer is among the leading causes of deaths in both men and women globally. Despite development in treatments, patients with cancer continue to suffer with limited treatment options. ADC has emerged as a significant therapy for lung cancer as it has tumor specificity and powerful tumor-killing effect.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/754

The report is an investigative study of the technological developments and product advancements, along with a regional analysis for each product and application offered in the Antibody-Drug Conjugates market. The fundamental objective of the report is to give an insight into the workings of the Antibody-Drug Conjugates industry. It provides an accurate and strategic outlook of the market with a thorough assessment of the segments and sub-segments of the Antibody-Drug Conjugates market. It provides a panoramic view of the industry to offer a deeper understanding of the global industry.

Segments Covered in this report are:

Technology Outlook (Revenue, USD Billion; 2018–2028)
Cleavable Linker
Non-Cleavable Linker

Application Outlook (Revenue, USD Billion; 2018–2028)
Blood Cancer
Leukemia
Lymphoma
Brain Tumor
Ovarian Cancer
Breast Cancer
Lung Cancer
Others

End-use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Research Institute
Clinics

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/antibody-drug-conjugates-market

Regional Analysis:
The report further examines the Antibody-Drug Conjugates market in the key regions of the world with regard to production and consumption patterns, import/export, supply and demand ratio, revenue generation, market share and size, and presence of prominent players in the regions. The Antibody-Drug Conjugates report also covers the expansion plans undertaken by companies in the regions under the regional analysis section.

The regional analysis of the market comprises of production volume information, consumption volume and patterns, revenue, and growth rate for the forecast period of 2020-2028.
Regional Outlook (Revenue, USD Billion; 2018–2028)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
Israel
Rest Of MEA

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/754

Thank you for reading our report. Please get in touch with us for further queries about the report and our team will assist you according to your needs.

Explore more Emergen Research Reports @ https://www.emergenresearch.com/

Automotive Cybersecurity Market- https://www.emergenresearch.com/industry-report/automotive-cybersecurity-market

Phototherapy Devices Market- https://www.emergenresearch.com/industry-report/phototherapy-devices-market

Concrete Floor Coatings Market- https://www.emergenresearch.com/industry-report/concrete-floor-coatings-market

Nanopatterning Market- https://www.emergenresearch.com/industry-report/nanopatterning-market

Smart Glass Market- https://www.emergenresearch.com/industry-report/smart-glass-market

Computational Biology Market- https://www.emergenresearch.com/industry-report/computational-biology-market

About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Read our Press Release @ https://www.emergenresearch.com/press-release/global-antibody-drug-conjugates-market

Contact Us:

Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn